CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oppenheimer Adjusts Price Target on Connect Biopharma to $5 From $8, Keeps Outperform Rating

Negative
AI Analysis

Summary

Oppenheimer reduced its price target on Connect Biopharma from $8 to $5 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
-0.30
price_target_reductionanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on September 22, 2026 12:50 PM

Read Original